Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AngioDynamics Inc ANGO

Healthcare Medical Devices
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the... see more

Recent & Breaking News (NDAQ:ANGO)

AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million

Business Wire April 17, 2019

AngioDynamics' DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer

Business Wire April 17, 2019

Dow Slips Following Monday Hike

Press Releases April 2, 2019

The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial

Benzinga.com  April 2, 2019

AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results

Business Wire April 2, 2019

Earnings Scheduled For April 2, 2019

Benzinga.com  April 2, 2019

AngioDynamics to Present at the Needham Healthcare Conference

Business Wire April 1, 2019

AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

Business Wire April 1, 2019

OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy

Business Wire March 28, 2019

AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019

Business Wire March 12, 2019

AngioDynamics Wins Patent Infringement Dispute With Bard

Business Wire March 8, 2019

AngioDynamics to Present at the Barclays Global Healthcare Conference

Business Wire February 26, 2019

New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis — Consolidated Revenues, Company Growth, and Expectations for 2019

GlobeNewswire January 30, 2019

The Daily Biotech Pulse: Novavax Reports Positive Influenza Vaccine Trial Data, Flexion Warns Of Revenue Shortfall, Retrophin's New CEO

Benzinga.com  January 4, 2019

AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results

Business Wire January 4, 2019

Earnings Scheduled For January 4, 2019

Benzinga.com  January 4, 2019

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Business Wire December 20, 2018

AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019

Business Wire December 10, 2018

Consolidated Research: 2018 Summary Expectations for Mimecast, Shiloh Industries, Adverum Biotechnologies, AngioDynamics, Kimball Electronics, and Changyou — Fundamental Analysis, Key Performance Indications

GlobeNewswire October 16, 2018

51 Biggest Movers From Yesterday

Benzinga.com  September 28, 2018